Your browser doesn't support javascript.
loading
Total nucleated cell dose in graft is a better prognostic factor for survival in pediatric patients transplanted with bone marrow compared to CD34+, CD3+, or total mononuclear cell count.
Kupeli, Serhan; Inan, Gul; Ozkan, Ayse; Sezgin, Gulay; Bayram, Ibrahim; Tanyeli, Atila.
Afiliación
  • Kupeli S; Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Cukurova University Faculty of Medicine, Adana, Turkey.
  • Inan G; Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Cukurova University Faculty of Medicine, Adana, Turkey.
  • Ozkan A; Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Cukurova University Faculty of Medicine, Adana, Turkey.
  • Sezgin G; Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Cukurova University Faculty of Medicine, Adana, Turkey.
  • Bayram I; Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Cukurova University Faculty of Medicine, Adana, Turkey.
  • Tanyeli A; Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Cukurova University Faculty of Medicine, Adana, Turkey.
J Clin Apher ; 37(1): 19-24, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34694023

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Complejo CD3 / Trasplante de Células Madre Hematopoyéticas / Antígenos CD34 Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Clin Apher Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Complejo CD3 / Trasplante de Células Madre Hematopoyéticas / Antígenos CD34 Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Clin Apher Año: 2022 Tipo del documento: Article País de afiliación: Turquía